Anita Sridhar Iyer, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholera | 6 | 2023 | 785 | 1.630 |
Why?
|
| Cholera Vaccines | 3 | 2021 | 268 | 1.280 |
Why?
|
| Pneumococcal Vaccines | 6 | 2016 | 391 | 1.170 |
Why?
|
| Vibrio cholerae | 4 | 2023 | 806 | 1.150 |
Why?
|
| Antibodies, Bacterial | 8 | 2023 | 1470 | 0.870 |
Why?
|
| Desiccation | 1 | 2018 | 70 | 0.630 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 713 | 0.570 |
Why?
|
| Vaccination | 4 | 2016 | 3278 | 0.560 |
Why?
|
| Immunity, Active | 1 | 2016 | 60 | 0.550 |
Why?
|
| Serologic Tests | 1 | 2018 | 374 | 0.540 |
Why?
|
| Polysaccharides, Bacterial | 2 | 2014 | 578 | 0.500 |
Why?
|
| Specimen Handling | 1 | 2018 | 694 | 0.440 |
Why?
|
| Antibody Formation | 1 | 2016 | 1402 | 0.410 |
Why?
|
| HIV Seropositivity | 1 | 2016 | 971 | 0.360 |
Why?
|
| Streptococcus pneumoniae | 2 | 2014 | 714 | 0.350 |
Why?
|
| Vibrio cholerae O1 | 2 | 2021 | 242 | 0.340 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 3176 | 0.340 |
Why?
|
| Immunoglobulin M | 5 | 2021 | 1537 | 0.300 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
| Immunoglobulin A | 3 | 2021 | 992 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.210 |
Why?
|
| Pneumococcal Infections | 2 | 2015 | 497 | 0.190 |
Why?
|
| Neuraminidase | 1 | 2021 | 210 | 0.190 |
Why?
|
| Refugees | 2 | 2017 | 511 | 0.180 |
Why?
|
| Cholera Toxin | 1 | 2021 | 556 | 0.170 |
Why?
|
| B-Lymphocytes | 4 | 2021 | 4665 | 0.170 |
Why?
|
| Cross Reactions | 1 | 2020 | 841 | 0.160 |
Why?
|
| Immunologic Memory | 3 | 2021 | 1348 | 0.160 |
Why?
|
| Sudan | 1 | 2018 | 83 | 0.160 |
Why?
|
| Disease Outbreaks | 2 | 2017 | 1772 | 0.150 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2017 | 298 | 0.140 |
Why?
|
| Hepatitis E | 1 | 2017 | 76 | 0.140 |
Why?
|
| Vaccines, Inactivated | 1 | 2016 | 184 | 0.140 |
Why?
|
| Inflammation | 1 | 2016 | 10638 | 0.140 |
Why?
|
| Immunoglobulin G | 4 | 2021 | 4560 | 0.130 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2015 | 246 | 0.120 |
Why?
|
| Immunity, Mucosal | 1 | 2017 | 490 | 0.120 |
Why?
|
| Administration, Oral | 2 | 2021 | 3913 | 0.110 |
Why?
|
| Frankia | 1 | 2012 | 2 | 0.110 |
Why?
|
| Bacterial Capsules | 1 | 2013 | 251 | 0.100 |
Why?
|
| Soil Microbiology | 1 | 2012 | 87 | 0.100 |
Why?
|
| Bacterial Load | 1 | 2012 | 153 | 0.100 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2017 | 1366 | 0.100 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 1978 | 0.090 |
Why?
|
| Cell Communication | 1 | 2017 | 1621 | 0.090 |
Why?
|
| Interleukin-6 | 2 | 2017 | 3200 | 0.090 |
Why?
|
| Keratin-19 | 1 | 2009 | 33 | 0.090 |
Why?
|
| Keratin-7 | 1 | 2009 | 57 | 0.090 |
Why?
|
| Adenoma, Liver Cell | 1 | 2009 | 33 | 0.080 |
Why?
|
| Immunophenotyping | 1 | 2013 | 1880 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2017 | 4420 | 0.080 |
Why?
|
| Antigens, CD34 | 1 | 2009 | 657 | 0.070 |
Why?
|
| Child, Preschool | 6 | 2021 | 41006 | 0.070 |
Why?
|
| Humans | 17 | 2023 | 744343 | 0.060 |
Why?
|
| Age Factors | 3 | 2021 | 18370 | 0.060 |
Why?
|
| C-Reactive Protein | 1 | 2016 | 3778 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2013 | 4026 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2009 | 1602 | 0.050 |
Why?
|
| Adult | 8 | 2021 | 214055 | 0.050 |
Why?
|
| Antibody-Producing Cells | 1 | 2021 | 143 | 0.050 |
Why?
|
| Child | 6 | 2023 | 77709 | 0.050 |
Why?
|
| Male | 9 | 2021 | 350118 | 0.050 |
Why?
|
| Bangladesh | 1 | 2023 | 687 | 0.050 |
Why?
|
| Infant | 3 | 2017 | 35136 | 0.050 |
Why?
|
| Zambia | 1 | 2021 | 261 | 0.050 |
Why?
|
| Middle Aged | 7 | 2021 | 213383 | 0.050 |
Why?
|
| Pandemics | 1 | 2020 | 8388 | 0.050 |
Why?
|
| Female | 9 | 2021 | 380194 | 0.050 |
Why?
|
| Adolescent | 6 | 2021 | 85781 | 0.050 |
Why?
|
| Young Adult | 5 | 2021 | 56430 | 0.050 |
Why?
|
| HIV Infections | 2 | 2015 | 16718 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 12072 | 0.040 |
Why?
|
| Aged | 4 | 2020 | 163280 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2020 | 40561 | 0.040 |
Why?
|
| Hepatitis Antibodies | 1 | 2017 | 73 | 0.040 |
Why?
|
| Shigella | 1 | 2017 | 74 | 0.040 |
Why?
|
| Dysentery, Bacillary | 1 | 2017 | 75 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2016 | 25625 | 0.030 |
Why?
|
| Hepatitis E virus | 1 | 2017 | 71 | 0.030 |
Why?
|
| Diarrhea | 1 | 2023 | 1348 | 0.030 |
Why?
|
| Formaldehyde | 1 | 2017 | 353 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 2017 | 401 | 0.030 |
Why?
|
| Transmembrane Activator and CAML Interactor Protein | 1 | 2015 | 56 | 0.030 |
Why?
|
| Escherichia coli | 2 | 2017 | 4217 | 0.030 |
Why?
|
| Vaccines, Conjugate | 1 | 2015 | 333 | 0.030 |
Why?
|
| Escherichia coli Infections | 1 | 2017 | 532 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2017 | 1341 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2009 | 4253 | 0.030 |
Why?
|
| Interleukins | 1 | 2017 | 791 | 0.030 |
Why?
|
| Diamines | 1 | 2012 | 59 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2017 | 1200 | 0.030 |
Why?
|
| Feces | 1 | 2017 | 1401 | 0.030 |
Why?
|
| Cell Separation | 1 | 2017 | 1751 | 0.020 |
Why?
|
| Organic Chemicals | 1 | 2012 | 211 | 0.020 |
Why?
|
| Benzothiazoles | 1 | 2012 | 248 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2013 | 793 | 0.020 |
Why?
|
| Prevalence | 2 | 2017 | 15226 | 0.020 |
Why?
|
| Polymers | 1 | 2017 | 1621 | 0.020 |
Why?
|
| Oxidoreductases | 1 | 2012 | 424 | 0.020 |
Why?
|
| Focal Nodular Hyperplasia | 1 | 2009 | 32 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2017 | 3206 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2012 | 1100 | 0.020 |
Why?
|
| DNA Primers | 1 | 2012 | 2892 | 0.020 |
Why?
|
| Quinolines | 1 | 2012 | 732 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2013 | 1607 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2017 | 5524 | 0.020 |
Why?
|
| Anti-Retroviral Agents | 1 | 2015 | 1715 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3870 | 0.020 |
Why?
|
| Gene Expression | 1 | 2017 | 7799 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2009 | 1641 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2013 | 5974 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 4803 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 18111 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 11366 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2017 | 23403 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 12959 | 0.010 |
Why?
|
| Time Factors | 1 | 2013 | 40075 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 72290 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 57776 | 0.000 |
Why?
|